Silo Pharma, Inc.

Q2 2025 13F Holders

Symbol
SILO
CUSIP
82711P201
Type
Equity
Class
COM NEW
Num filings
14
Total reported value, excl. options
$256 k
Manager Report Date Value ($000) Shares Option Type